Iron, Cobalt, Nickel, Vanadium, Molybdenum, Or Palladium Patents (Class 424/646)
-
Patent number: 8877244Abstract: The present invention provides a stabilized pesticidal composition comprising at least one granular substrate material containing at least one metal chelate of 2-(2?-nitro-4?-methylsulphonylbenzoyl)-1,3-cyclohexanedione, a method of producing a stabilized granular pesticidal composition which comprises incorporating a metal chelate of 2-(2?-nitro-4?-methylsulphonylbenzoyl)-1,3-cyclohexanedione in to or on to a granular substrate material; and a method of killing or controlling weeds or unwanted vegetation (without damaging beneficial plants and or seeds) which comprises applying a herbicidally effective amount of the stabilized granular pesticide composition of the invention to the foliage, tissue or locus of the weeds or unwanted vegetation.Type: GrantFiled: June 22, 2011Date of Patent: November 4, 2014Assignee: Syngenta Crop Protection LLCInventors: John R. James, Andrew Pearson, Johnny D. Reynolds
-
Publication number: 20140322315Abstract: Provided herein are methods and compositions for treating ischemia or a disease or disorder that causes ischemia comprising contacting a subject with cysteamine, a cysteamine derivative, cystamine or a cystamine derivative. The disclosure also provides methods of modulating adiponectin levels in a subject comprising contact a subject with cysteamine, a cysteamine derivative, cystamine or a cystamine derivative.Type: ApplicationFiled: November 21, 2012Publication date: October 30, 2014Applicant: The Regents of the University of CaliforniaInventors: Ranjan Dohil, Susan A. Phillips
-
Patent number: 8871232Abstract: A wipe that includes a bacteriostatic agent that contains cations having an affinity for the negatively charged cell walls of bacteria is provided. The affinity of the bacteriostatic agent for the bacteria allows the wipe to capture bacteria, thereby removing them from a surface and also inhibiting their spread to other surfaces that may contact the wipe. Of particular advantage, the bacteriostatic agent may help protect against the spread or infection of pathogens without the use of chemicals, such as antiseptics or antibiotics. Still further, the wipe of the present invention also contains a solvatochromatic indicator that undergoes a color change in the presence of a broad spectrum of bacteria. Thus, when the wipe captures bacteria, the indicator undergoes a color change that signals to the user that the wipe is functioning properly. The lack of a color change may likewise provide the user with the assurance that the area is generally free of bacteria and clean.Type: GrantFiled: December 13, 2007Date of Patent: October 28, 2014Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Stephanie M. Martin, John Gavin MacDonald, Bao Trong Do
-
Publication number: 20140314875Abstract: The present invention relates to a composition for the use in improving vascular health, including treating and preventing vascular diseases and diseases related thereto, using a botanical extract of oil palm vegetation liquor from the palm oil milling process.Type: ApplicationFiled: July 2, 2014Publication date: October 23, 2014Inventors: Mahinda Abeywardena, Ravigadevi Sambanthamurthi, Yew Ai Tan, Kalyana Sundram P. Manickam, Mohd Basri Wahid
-
Publication number: 20140302154Abstract: Embodiments herein relate to the production of biocompatible magnetic nanoparticles with a high SAR-value which produce a large amount of heat when exposed to an alternating magnetic field. The produced heat can be used among others for therapeutic purposes, in particular for combating cancer.Type: ApplicationFiled: May 15, 2014Publication date: October 9, 2014Applicant: MagForce AGInventors: Norbert WALDOEFNER, Kerstin STIEF
-
Publication number: 20140294981Abstract: A nanocomposite includes carbon-encapsulated transition metal oxide nanoparticles. The carbon-encapsulated transition metal oxide nanoparticles comprise a transition metal oxide core having a diameter of from 5 nm to 50 nm covered by a graphitic coating having a thickness of from 1 nm to 5 nm.Type: ApplicationFiled: September 26, 2012Publication date: October 2, 2014Inventors: Maximilian Fichtner, Horst Hahn, Raju Prakash
-
Patent number: 8846109Abstract: The invention relates to a treatment solution for treating wounds, preferably for liquid wound treatment of acute and chronic wounds, made of an aqueous solution including zinc, iron, and acid, wherein the per liter proportion of zinc is 10 to 100 mg, the proportion of iron is 6.5 to 60 mg, and the proportion of acid is selected such that the pH value of the treatment solution is 2.5 to 3.5.Type: GrantFiled: February 5, 2010Date of Patent: September 30, 2014Assignee: Nawa Heilmittel GmbHInventor: Thomas Riesinger
-
Publication number: 20140271558Abstract: Beta glucan and fulvic acid can be combined in a dietary supplement as a partial substitute or complete replacement for blue green algae and/or brown seaweed and its derivatives. Beta glucans are widely available as derivatives of Brewer's yeast and fulvic acid is widely available as well. These supplements are not subject to the vagaries of weather-influence growing seasons as is the case with blue green algae and brown seaweed. When combined, beta glucan and fulvic acid can provide a less costly dietary supplement than blue green algae and brown seaweed and its derivatives such as fucoidan.Type: ApplicationFiled: March 12, 2014Publication date: September 18, 2014Applicant: Cappellos, Inc.Inventor: John V. Cappello
-
Publication number: 20140255458Abstract: According to an aspect of the invention, injectable bulking compositions are provided which contain the following: (a) fibers that are configured to prevent migration to locations in the body remote from the injection site, for example, because they have a minimum length that is sufficiently large to prevent migration of the fibers and/or because they have surface features that stimulate host tissue response to lock the fibers in position and (b) a carrier in an amount effective to render the composition injectable.Type: ApplicationFiled: May 20, 2014Publication date: September 11, 2014Applicant: Boston Scientific Scimed, Inc.Inventors: Jianmin Li, Michael Madden
-
Patent number: 8821945Abstract: Embodiments provide devices, systems and methods for the transdermal delivery of chelated compounds. One embodiment provides a method for the iontophoretic transdermal delivery of a chelated iron complex for the treatment of anemia. A first patch comprising an active electrode and a chelated iron complex is applied to the skin; a second patch containing an electrode is also applied. An electrical current is then delivered to the skin from the active electrode. The chelated complex is transported across the skin via electromotive force from the current, with the iron being substantially chromogenically unreactive with the skin during transport so that there is little or no tattooing of the skin due to the formation of insoluble oxidative products. The complex is then dissociated by phagocytosis or related process to release the iron where it may be bound by transferrin or ferritin and carried to other sites for storage or metabolic use.Type: GrantFiled: July 7, 2009Date of Patent: September 2, 2014Assignee: Fe3 Medical, Inc.Inventors: Mir Imran, Mir Hashim, Sanjay Patel, Ronald J. Berenson
-
Publication number: 20140220152Abstract: Disclosed herein is a non-human animal model of protein aggregation cardiomyopathy. Also disclosed are compositions and methods of treating or preventing a condition in a subject caused or exacerbated by reductive stress. Also disclosed are compositions and methods of predicting, detecting, or monitoring reductive stress in a subject.Type: ApplicationFiled: September 12, 2013Publication date: August 7, 2014Applicant: University of Utah Research FoundationInventors: Ivor J. Benjamin, Namakal S. Rajasekaran, Thomas P. Kennedy
-
Publication number: 20140219926Abstract: A biodegradable iron oxide nanoparticle gel for hyperthermia treatment of cancer includes a polysaccharide-based carrier matrix and starch-coated iron oxide nanoparticles. The gel has sufficient deformability to integrate into a diffuse tumor site, adheres to tissue and has sufficient mechanical properties to remain in place during hyperthermia treatment. The gel releases iron oxide nanoparticles for uptake by cancerous cells at the tumor margin.Type: ApplicationFiled: February 3, 2014Publication date: August 7, 2014Applicant: The Trustees Of Dartmouth CollegeInventors: Benjamin P. Cunkelman, Jennifer A. Tate, Alicia A. Petryk, P. Jack Hoopes, Robert J. Collier, Sara G. Thappa
-
Patent number: 8796476Abstract: Pest controlling compositions exhibiting enhanced pesticidal activity levels and methods for preparing the same are disclosed. In one embodiment, a method includes providing a liquid composition that includes at least one pesticide and at least one co-ingredient that enhances pesticidal activity of the composition compared to a composition dissimilar only in not having the at least one co-ingredient. The at least one co-ingredient may include at least one metal oxide, a combination of at least one transition metal salt and at least one proteinaceous material or a combination of at least one proteinaceous material and at least one polymeric material. The method further includes spray drying the liquid composition to provide a solid composition. In one aspect of this embodiment, the solid composition provided by the spray drying exhibits enhanced pesticidal activity compared to the liquid composition.Type: GrantFiled: April 27, 2010Date of Patent: August 5, 2014Assignee: Dow AgroSciences, LLCInventors: Stephen L. Wilson, Lei Liu, James D. Thomas, Raymond E. Boucher, Jr., James E. Dripps, Margaret S. Kempe, Martin C. Logan, Douglas J. Linscott, John M. Atkinson
-
Patent number: 8795739Abstract: The present invention relates to a food product which has been fortified in iron content, comprising a Fe3O4 sphere. The present invention also relates to an iron-containing additive for use in the above food product, in the form of a Fe3O4 sphere. The present invention further relates to a method for preparing the above food product, comprising the steps of adding or mixing the iron-containing additive in solid or dispersed form with the food product, wherein the iron-containing additive is in the form of a Fe3O4 sphere.Type: GrantFiled: June 22, 2012Date of Patent: August 5, 2014Assignee: Magqu Co. Ltd.Inventors: Shieh-Yueh Yang, Che-Chuan Yang
-
Publication number: 20140212508Abstract: A Copper/Zinc superoxide dismutase (Cu/Zn SOD) composition comprising a therapeutically effective amount of ionic mineral(s) in a ligand complex and a pharmaceutically acceptable carrier for the neutralization of superoxide produced trauma and/or stress-related conditions including, but not limited to, conditions such as myotrophic lateral sclerosis (ALS). The composition may also include other supporting adjutants such as bioavailable magnesium, manganese, selenium and other minerals that can support the nervous system and other vitamins and glutathione and other nutrients. Botanical extracts, urea, other supplements helpful for protection and re-enforcement of the immune system are discussed.Type: ApplicationFiled: April 3, 2014Publication date: July 31, 2014Inventor: John Wayne Kennedy
-
Patent number: 8790712Abstract: The present invention is drawn to a method of inducing thymocyte proliferation in a vertebrate animal with an impaired immune system comprising administering ?-aminolevulinic acid or a salt thereof every day in succession. The method further comprises administering at least one mineral.Type: GrantFiled: August 26, 2005Date of Patent: July 29, 2014Assignees: Cosmo Oil Co., Ltd., SBI Pharmaceuticals Co., Ltd.Inventors: Masao Kondo, Naomi Aiba, Setsuko Miyanari, Tohru Tanaka, Takaya Suzuki, Masahiro Ishizuka
-
Patent number: 8785194Abstract: The present invention provides a cell culture medium formulation that supports the in vitro cultivation, particularly in suspension, of mammalian cells, particularly epithelial cells and fibroblast cells, and methods for cultivating mammalian cells in suspension in vitro using these media. The media comprise a basal medium and a polyanionic or polyanionic compound, preferably a polysulfonated or polysulfated compound, and more preferably dextran sulfate. The present invention also provides chemically defined, protein-free eukaryotic cell culture media comprising an iron chelate and zinc, which is capable of supporting the growth (and particularly the high-density growth of mammalian cells) in suspension culture, increasing the level of expression of recombinant protein in cultured cells, and/or increasing virus production in cultured cells.Type: GrantFiled: May 8, 2009Date of Patent: July 22, 2014Assignee: Life Technologies CorporationInventors: Stephen Gorfien, Richard Fike, Glenn Godwin, Joyce Dzimian, David A. Epstein, Dale Gruber, Don McClure, Paul Price
-
Publication number: 20140200138Abstract: The present invention provides a composition comprising an acidified aqueous solution of (1) micro colloidal silicic acid, (2) boric acid, and (3) a water absorbing additive, having a pH value of equal to or less than 1, wherein the micro colloidal silicic acid has particle sizes in the range of 1-8 nm, especially in the range of 1.5-6 nm. The invention also provides a particulate product obtainable by the method according to claim 18, wherein the particles comprise (1) silicic acid, (2) boric acid, and (3) the water absorbing additive, and wherein at least 90% of the particles in the particulate product have particle sizes in the range of 0.3-5 ?m.Type: ApplicationFiled: December 13, 2013Publication date: July 17, 2014Applicant: Barlaa B.V.Inventors: Henk Maarten LAANE, Walter Ferdinand WITTERLAND
-
Patent number: 8778411Abstract: The present invention relates to a heat-generating composition, comprising a hetero-structure nanomaterial which comprises (a) a first material comprising at least one component selected from the group consisting of a metal, a metal chalcogen, a metal pnicogen, an alloy and a multi-component hybrid structure thereof; and (b) a second material comprising at least one component selected from the group consisting of metal, metal chalcogen, metal pnicogen, alloy and the multi-component hybrid structure thereof; wherein the first material is enclosed in the second material; wherein at least one of the first material and the second material comprise a magnetic material. The specific loss power of the present nanomaterial is much higher than that of conventional nanomaterials (e.g., 40-fold higher than commercially accessible Feridex) and may be controlled by changing compositions or ratios of the first material and/or the second material.Type: GrantFiled: May 20, 2009Date of Patent: July 15, 2014Assignee: Industry-Academic Cooperation Foundation, Yonsei UniversityInventors: Jin Woo Cheon, Jung Tak Jang
-
Patent number: 8771751Abstract: The invention relates to a medical implant made of a metallic material. After fulfilling its temporary support function, the implant is degraded by corrosion at a predetermined rate. Negative long-term effects are thus avoided.Type: GrantFiled: August 17, 2011Date of Patent: July 8, 2014Assignee: Biotronik AGInventors: Bernd Heublein, Gerd Hausdorf
-
Patent number: 8771699Abstract: Embodiments herein relate to the production of biocompatible magnetic nanoparticles with a high SAR-value which produce a large amount of heat when exposed to an alternating magnetic field. The produced heat can be used among others for therapeutic purposes, in particular for combating cancer.Type: GrantFiled: January 9, 2009Date of Patent: July 8, 2014Assignee: Magforce AGInventors: Norbert Waldoefner, Kerstin Stief
-
Publication number: 20140186466Abstract: Disclosed are compositions of matter useful for the treatment of diabetes. In one embodiment a nutraceutical composition is administered to a patient in need, said composition comprising of one or more ingredients selected from a group consisting of: magnesium, chromium picolinate, alpha lipoic acid, Garcina indica, holy basil, Morodica charantica, cinnamon, Salacia reticulate, Salacia oblonga, Gymnema sylvestre, nopal cactus, fenu greek, vanadium, 1-carnitine, and vitamin D3.Type: ApplicationFiled: December 31, 2013Publication date: July 3, 2014Applicant: Creative Medical Health Inc.Inventor: Amit Patel
-
Publication number: 20140178331Abstract: Methods for preconditioning and/or providing neuroprotection to the animal central nervous system against the effects of cerebral hemorrhage and subarachnoid hemorrhage. Therapeutic agents are administered to the upper third of the nasal cavity to bypass the blood-brain barrier and access the central nervous system directly to avoid unwanted and potentially lethal side effects. Therapeutic agents include those substances that interact with iron and/or copper such as iron chelators, copper chelators, and antioxidants. A particular example of such therapeutic agents is the iron chelator deferoxamine (DFO). An effective amount of DFO may be administered to the upper third of the nasal cavity of a patient at risk for, or diagnosed with, cerebral hemorrhage and subarachnoid hemorrhage. The effective amount of DFO is delivered directly to the patient's central nervous system for preconditioning, preventing and/or treating the cerebral hemorrhage and subarachnoid hemorrhage.Type: ApplicationFiled: October 25, 2013Publication date: June 26, 2014Applicant: HealthPartners Research FoundationInventors: William H. Frey II, Samuel Scott Panter, Leah Ranae Bresin Hanson
-
Publication number: 20140178498Abstract: Proposed is a method for the production of at least one composite layer (7) in which nanoparticles are embedded in a polymer matrix, comprising the following steps: 1. in situ production and aerosol deposition of nano-particles onto a substrate (1) for the formation of a particle film (2) on the substrate (1); 2 immersing said particle film (2) with a polymer solution or a liquid polymer precursor material for the formation of the composite layer (7).Type: ApplicationFiled: June 13, 2012Publication date: June 26, 2014Applicant: ETH ZURICHInventors: Sotiris E. Pratsinis, Georgios Sotiriou, Christoph O. Blattmann
-
Patent number: 8753561Abstract: Methods for processing substrate surfaces comprising metallic nanoparticles are disclosed. The methods involve providing a substrate surface comprising metallic nanoparticles, and exposing the substrate surface to a plasma.Type: GrantFiled: June 20, 2008Date of Patent: June 17, 2014Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Yann-Per Lee, John-Bruce D. Green, Jeffrey Bloss, Ozlem Yardimci
-
Publication number: 20140161901Abstract: Dental compositions are disclosed. A dental composition can include a reaction produce of a reaction mixture comprising a first mixture and a second mixture. The first mixture can include a ceramic based biomaterial, and the second mixture can include mineral trioxide aggregate and a phosphoric acid monomer.Type: ApplicationFiled: December 10, 2013Publication date: June 12, 2014Applicant: Zimmer Dental, Inc.Inventors: Jin Whan Lee, Hai Bo Wen, Jeffrey Bassett, Mike Warner
-
ANTIMICROBIAL AGENTS AND METHODS FOR USE THEREOF IN THE ABATEMENT OF FOOD BORNE PATHOGENIC ORGANISMS
Publication number: 20140154337Abstract: Antimicrobial agents and methods for the abatement of food borne pathogenic organisms—particularly, Escherichia coli—include the steps of providing a specifically formulated humic composition and, thereafter, applying the humic composition as an antimicrobial agent for the abatement of Escherichia coli. In at least some applications of the present invention, other substances are introduced in combination with the humic composition thereby synergistically providing in certain applications a greater effect than otherwise independently obtainable.Type: ApplicationFiled: February 5, 2014Publication date: June 5, 2014Inventor: Lynn C. Wilford -
Publication number: 20140154324Abstract: The present invention relates to a method for producing a suspension of agglomerates of magnetic alkoxysilane-coated metal nanoparticles, wherein an aqueous suspension of magnetic metal nanoparticles is incubated with alkoxysilane, wherein the incubation is carried out essentially in the absence of an organic solvent. The present invention further relates to suspension of agglomerates of magnetic alkoxysilane-coated metal containing nanoparticles obtainable by the method of the present invention and to a composition comprising agglomerates of magnetic alkoxysilane-coated metal nanoparticles, wherein the agglomerates have an average size of 30 to 450 nm, preferably of 50 to 350 nm and especially of 70 to 300 nm as determined by light scattering.Type: ApplicationFiled: August 7, 2012Publication date: June 5, 2014Inventors: Norbert Waldöfner, Andreas Jordan
-
Publication number: 20140154292Abstract: Articles have a glass layer on a substrate. The glass layer has antimicrobial properties via a metal or metal alloy. The glass layer is made using a doped glass frit which may be deposited by screen printing. The CTE of the glass layer and the substrate can be matched.Type: ApplicationFiled: November 21, 2013Publication date: June 5, 2014Applicant: CORNING INCORPORATEDInventors: Nicholas Francis Borrelli, Melinda Ann Drake, Robert Michael Morena
-
Publication number: 20140147514Abstract: A process for extracting vitamins and minerals from a first plant matter(s) is disclosed wherein the said first plant matter(s) is treated with acidic matter followed by extraction with water. Said treatment converts the water-insoluble vitamins and minerals into water-soluble forms leading to a more comprehensive extraction with better yields of the plant constituents. Suitable selection of the first and second plant matter(s) and their proportions yields an extract that is a ready-made formulation of the desired vitamins and minerals in RDA quantities. Other advantages are reduced processing times and processing steps. Extraction of guava fruits, guava leaves, holy basil leaves, lemon peels, amla fruits, annato seeds, Wrightia tinctoria, Lantana camara, bamboo shoots, mustard seeds, and curry leaves is described.Type: ApplicationFiled: July 30, 2012Publication date: May 29, 2014Inventors: Ramaswamy Rajendran, Kamala Rajendran
-
Publication number: 20140141098Abstract: Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways.Type: ApplicationFiled: August 26, 2013Publication date: May 22, 2014Applicant: Pulmonox Technologies CorporationInventors: Bruce R. Murray, Christopher C. Miller, Douglas R. Hole
-
Publication number: 20140141052Abstract: There is disclosed a substrate with an electron donating surface, characterized in having metal particles on said surface, said metal particles comprising palladium and at least one metal selected from the group consisting of gold, ruthenium, rhodium, osmium, iridium, and platinum, wherein the amount of said metal particles is from about 0.001 to about 8 ?g/cm2.Type: ApplicationFiled: January 28, 2014Publication date: May 22, 2014Applicant: Bactiguard ABInventors: Mattias Ohrlander, Billy Södervall
-
Publication number: 20140127325Abstract: The invention relates to lipid formulated double-stranded ribonucleic acid (dsRNA) targeting a hepcidin antimicrobial peptide (HAMP) and/or HAMP-related gene, and methods of using the dsRNA to inhibit expression of HAMP and/or HAMP-related genes.Type: ApplicationFiled: June 21, 2012Publication date: May 8, 2014Inventors: Brian Bettencourt, Akin Akinc, Alfica Sehgal, Don Foster, Stuart Milstein, Satyanarayana Kuchimanchi, Martin A. Maier, Klaus Charisse, Kallanthottathil Rajeev
-
Publication number: 20140128791Abstract: A method of adjusting a patient's undesired hematocrit and/or hemoglobin concentration to a value within a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen includes obtaining patient parameters required for input into a model for predicting the patient's hematocrit and/or hemoglobin concentration at a predetermined time with a selected ESA administration regimen, the model including iron homeostasis, and employing the patient parameters and an initially selected ESA administration regimen in the model to predict the patient's hematocrit and/or hemoglobin concentration at the predetermined time with the initially selected ESA administration regimen. The method then includes administering ESA to the patient with an ESA administration regimen predicted to adjust the patient's hematocrit and/or hemoglobin concentration to the desired range at the predetermined time. The method can be implemented in a hemodialysis system.Type: ApplicationFiled: November 5, 2013Publication date: May 8, 2014Applicant: Fresenius Medical Care Holdings, Inc.Inventors: DORIS HELENE FUERTINGER, FRANZ KAPPEL, PETER KOTANKO, NATHAN W. LEVIN, STEPHAN THIJSSEN
-
Publication number: 20140120180Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.Type: ApplicationFiled: October 28, 2013Publication date: May 1, 2014Applicant: CYTOCHROMA DEVELOPMENT INC.Inventors: Norman Bryson Roberts, Maurice Webb Chester, Benjamin Joseph
-
Patent number: 8703211Abstract: The invention relates to the treatment and prophylaxis of cancer. In particular, the invention relates to a pharmaceutical agent comprising strontium, amino acid(s) and mineral element(s), and its use in the preparation of an agent useful for the treatment and prophylaxis of cancer. The invention also relates to a method for treatment and prophylaxis of cancer.Type: GrantFiled: November 30, 2009Date of Patent: April 22, 2014Assignee: Oy Neurofood ABInventor: Thomas Tallberg
-
Patent number: 8703166Abstract: Antimicrobial and algaecidal products are disclosed. In general, the antimicrobial or algaecidal products can be adhered to structural components of buildings and include particles that, when combined with water, produce a solution that is toxic to organisms such as algae. The products provide an algaecidal wash as water percolates on, or through the product, and can prevent or control growth of unsightly algae and other microbes.Type: GrantFiled: January 20, 2011Date of Patent: April 22, 2014Inventor: John Flynn
-
Publication number: 20140099350Abstract: The present invention relates to micro-sized particles having anti-biocontaminant properties. Each particle is comprised of a central metal core, or support structure, (for example, alumina oxide) and has on its surface, one or more anti-biocontaminant metals and at least one redox agent.Type: ApplicationFiled: March 26, 2013Publication date: April 10, 2014Inventor: Dynamic Adsorbents, Inc.
-
Publication number: 20140099346Abstract: An iron oxide containing effect pigment, and methods for producing and using the same are discussed. The iron oxide containing effect pigment may include an iron oxide coating in direct contact with a particulate substrate, which may have high levels of hematite, magnetite, or maghemite; and low amounts of toxic metals. A method for producing the pigment may include chemical vapor deposition of iron pentacarbonyl onto a particulate substrate. The iron oxide containing effect pigments may be incorporated into compositions, such as cosmetics.Type: ApplicationFiled: October 2, 2013Publication date: April 10, 2014Applicant: BASF CorporationInventors: Juergen Walker, Gabe Uzunian, Raimund Schmid, Aron Wosylus, Christoph Schwidetzky
-
Patent number: 8691776Abstract: A process for preparing parenteral iron-saccharidic complexes, and the complexes produced, comprising: (1) providing an aqueous solution or dispersion including (i) Fe(III) and (OH)? ions and (ii) at least one saccharide, to form a reaction mixture, where the molar ratio of (i):(ii) is about 30:1 to about 1:30; and the mixture temperature and pH are at or above the complex assembly point (CAP); and (2) maintaining temperature and pH at or above the CAP for a time sufficient to form an iron-saccharidic complex having a molecular weight of about 25,000 Daltons or more. Control of the temperature and pH efficiently produces a high molecular weight complex. The complex can be separated by precipitation, dialysis and/or column fractionation and, if desired, dried, e.g., lyophilized or spray dried. The process can controllably synthesize complexes of varying molecular weight and/or chemical composition, particularly sodium ferric gluconate and ferric hydroxide-sucrose.Type: GrantFiled: May 16, 2011Date of Patent: April 8, 2014Assignee: Chromaceutical Advanced Technologies,Inc.Inventors: Robert A. Beck, Robert A. Mateer, Jr., John Kowalski
-
Publication number: 20140093572Abstract: A method, composition and structure to treat fouling. In one embodiment, the method of treating fouling includes providing a structure including a first component of a base material and a second component of an energetically activated nanostructure, and applying a stimuli to the structure that effectuates an increase or decrease in the temperature of the energetically activated nanostructure. The increase or decrease in the temperature of the energetically activated nanostructure modifies the chemical and/or mechanical properties of the base material. The modifications to the chemical and/or mechanical properties of the base material obstruct fouling of the structure.Type: ApplicationFiled: May 4, 2012Publication date: April 3, 2014Applicant: UT-BATTELLE, LLCInventors: Mitchel J. Doktycz, David P. Allison, Charles F. Barnett, Scott T. Retterer
-
Publication number: 20140093550Abstract: A system of stabilized metallic nanoparticles is described that includes metallic nanoparticles coated with a hydrophilic polymer that has been reacted with a catechol-based ligand. Also described are stable, metallic nanoparticles that can be used alone or in conjunction with biocides, antibiotics, or other treatment systems in a method to disrupt a biofilm and facilitate its removal from a surface. The nanoparticles can be metal, such as platinum, silver, iron (II, III) oxide (Fe3O4), and gold. The nanoparticles can be sterically stabilized, such as with a polymer, or charge stabilized, such as with citrate, resulting in nanoparticles having modified surfaces. This surface modification is thought to enhance the stability of the nanoparticles and decrease their likelihood of aggregation, which, in turn, enhances their ability to disrupt and disperse existing biofilms.Type: ApplicationFiled: October 3, 2013Publication date: April 3, 2014Applicant: Clemson UniversityInventors: Tamara L. McNealy, Olin Thompson Mefford, IV, Steven L. Saville
-
Publication number: 20140088669Abstract: Particles and related methods are disclosed.Type: ApplicationFiled: September 27, 2012Publication date: March 27, 2014Applicant: Boston Scientific Scimed, Inc.Inventors: Janel L. Lanphere, John Spiridigliozzi, Orla McCullagh, Paul D. DiCarlo
-
Publication number: 20140072642Abstract: The invention relates to the use of endothelial progenitor cells (EPC) that comprises superparamagnetic particle aggregates which are able for the preparation of a medicament. Particular nanoparticle aggregates with a coating of compounds with net negative charge, and the method for obtaining them are also disclosed.Type: ApplicationFiled: March 12, 2012Publication date: March 13, 2014Applicants: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCAInventors: Joan Montaner Villalonga, Anna Rosell Novel, Anna Roig Serra
-
Patent number: 8663607Abstract: Compositions containing ferrate(VI) are disclosed. Also, methods are disclosed that utilize ferrate(VI).Type: GrantFiled: March 10, 2008Date of Patent: March 4, 2014Assignee: Battelle Memorial InstituteInventors: Bruce F. Monzyk, Michael J. Murphy, Chad Cucksey, F. Michael von Fahnestock, Andrew J. Savage, David N. Clark
-
Publication number: 20140056993Abstract: The present invention relates to an antimicrobial composition suitable for use on skin and wounds comprising a source of an antimicrobial metal ion and a quaternary cationic surfactant.Type: ApplicationFiled: April 5, 2012Publication date: February 27, 2014Applicant: CONVATEC TECHNOLOGIES, INC.Inventor: David Parsons
-
Publication number: 20140044685Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and citrulline. The composition may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, ?-keto-glutarate, eicosapentaenoic acid, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 13, 2014Applicant: NESTEC S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Publication number: 20140030241Abstract: Nutritional compositions having dietary nucleotides, ?-3 fatty acids and citrulline are provided. The nutritional compositions may be formulated to improve T cell function, increase arginine availability in vivo, regulate myeloid-derived suppressor cells (“MDSC”), and decrease the risk and/or severity of infection after surgery or trauma. Methods of making, using and administering such nutritional compositions to individuals in need of same are also provided. Methods for modulating the affects of MDSC's are also provided.Type: ApplicationFiled: March 15, 2012Publication date: January 30, 2014Applicant: NESTEC S.A.Inventor: Norman Alan Greenberg
-
Publication number: 20140030359Abstract: The present invention provides methods and compositions for treating thyroid-related medical conditions. Many thyroid-related medical conditions exist that go undiagnosed and untreated. These conditions may be prevented and treated with reduced folates and vitamin B12. Administration of reduced folates and vitamin B12 will prevent or treat cerebrospinal folate deficiency, which is linked to thyroid-related medical conditions. Administration of reduced folates and vitamin B12 will also prevent or treat conditions associated with masked megaloblastic anemia and hypothyroidism, and other conditions brought upon through improper thyroid function. Additionally, it is commonplace to treat many thyroid conditions with anti-thyroid drugs or thyroid stimulating drugs. This practice alone is also responsible for causing, or not beneficially addressing, adverse conditions that can be prevented or treated through the methods and compositions discussed herein.Type: ApplicationFiled: October 1, 2013Publication date: January 30, 2014Inventor: Linzy O. Scott, III
-
Publication number: 20140017339Abstract: Disclosed herein are materials and methods for treating patients that have been exposed to pathological levels on ionizing radiation. These materials and methods include administering to a patient in thereof at least one dose of a compound such as prostaglandin (PGE2) as soon as possible after the patient has been exposed to the radiation. Additional embodiments include treating a patient exposed to radiation with at least one dose of a compound that modulates PGE2 activity such as non-steroidal anti-inflammatory compound. Some methods include a first step of administering PGE2 or another compound that binds as soon as possible after exposure to radiation followed by a delayed dosing with at least one compound such as meloxicam that interferes with PGE2 activity.Type: ApplicationFiled: November 7, 2011Publication date: January 16, 2014Applicant: Indiana University Research and Technology Corp.Inventors: Louis M. Pelus, Jonathan Hoggatt